Update on Side effects of COVID-19 vaccines in Switzerland As of 20 Apr 2021, Swissmedic has evaluated 1485 reports of suspected adverse […]
Blog Archive
1
Adverse reaction reporting in New Zealand (2020)
Adverse reaction reporting in New Zealand (2020) On 22 April 2021, Med Safe published 2020-year Adverse reaction reporting statistics in New Zealand. […]
0
South African Health Products Regulatory Authority Launches the Med Safety App for Self Reporting
South African Health Products Regulatory Authority Launches the Med Safety App for Self Reporting On 22 Apr 2021, South African Health Products […]
0
Safety signal (risk of thrombosis in combination with thrombocytopenia) VAXZEVRIA/COVID-19 Vaccine
Safety signal (risk of thrombosis in combination with thrombocytopenia) VAXZEVRIA/COVID-19 Vaccine European Medicines Agency EMA) has published Direct healthcare professional communications (DHPC) […]
1
Remdesivir Safety Profile
Remdesivir Safety Profile Remdesivir authorized in the EU as Veklury Remdesivir is an antiviral medicine used to treat coronavirus disease 2019 (COVID-19). […]
0
Medical device safety information produced by the MHRA
Medical device safety information produced by the MHRA On 12 Feb 2021, MHRA provided updates on Medical device safety information related to […]
0
Update on COVID-19 vaccines suspected adverse reactions (63) in Switzerland
On 05 February 2021, Swissmedic has evaluated 63 reports of suspected adverse drug reactions (ADR) to COVID-19 vaccinations in Switzerland (in collaboration […]
0
Drug Safety Communication (FDA) – Risk of serious heart related problems and cancer (tofacitinib)
Drug Safety Communication (FDA) – Risk of serious heart-related problems and cancer (tofacitinib) On 04 Feb 2021, the U.S. Food and Drug […]
0
V-safe
After Vaccination Health Checker – V-safe Centers for Disease Control and Prevention (CDC) has launched “V-safe” health screening tool to assist COVID-19 […]
0
FDA Approved Drugs December 2020
Here you can find FDA Approved Drugs in December 2020 This report includes NDAs, BLAs, ANDAs, approvals, and approved supplements to these […]
